APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review

Consensus guidelines for radiological diagnosis of hepatocellular carcinoma (HCC) have been drafted by several large international working groups. This article reviews the similarities and differences between the most recent guidelines proposed by the American Association for Study of Liver Diseases and the Asian Pacific Association for the Study of the Liver. Current evidence for the various imaging modalities for diagnosis of HCC and their relevance to the consensus guidelines are reviewed.

• Publication year

  2011

• Venue

  International Journal of Hepatology

• Publication date

  2011-04-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.4061/2011/519783PMID 22007313PMCID 3170828
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of hepatocellular carcinoma: An update

  2011influential reference
• Detection of small hypervascular hepatocellular carcinomas by EASL criteria: comparison with double-phase CT during hepatic arteriography.

  2011influential reference
• Validation of an extension of the international non‐invasive criteria for the diagnosis of hepatocellular carcinoma to the characterization of macroscopic portal vein thrombosis

  2011cited by this paper
• New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases.

  2011cited by this paper
• Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT.

  2011cited by this paper
• Hepatocellular carcinoma in cirrhotic patients at multidetector CT: hepatic venous phase versus delayed phase for the detection of tumour washout.

  2011cited by this paper
• Solid Hypervascular Liver Lesions: Accurate Identification of True Benign Lesions on Enhanced Dynamic and Hepatobiliary Phase Magnetic Resonance Imaging After Gadobenate Dimeglumine Administration

  2011cited by this paper
• CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis.

  2011cited by this paper
• Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinoma.

  2011cited by this paper
• Optimization of imaging diagnosis of 1-2 cm hepatocellular carcinoma: an analysis of diagnostic performance and resource utilization.

  2011cited by this paper
• Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)‐enhanced MRI: Added value of diffusion‐weighted imaging (DWI)

  2010cited by this paper
• Gadoxetic Acid (Gd-EOB-DTPA)-Enhanced MRI versus Gadobenate Dimeglumine (Gd-BOPTA)-Enhanced MRI for Preoperatively Detecting Hepatocellular Carcinoma: an Initial Experience

  2010cited by this paper
• Comparison of Portal Venous and Delayed Phases of Gadolinium-Enhanced Magnetic Resonance Imaging Study of Cirrhotic Liver for the Detection of Contrast Washout of Hypervascular Hepatocellular Carcinoma

  2010cited by this paper
• The Impact of Vascular and Nonvascular Findings on the Noninvasive Diagnosis of Small Hepatocellular Carcinoma Based on the EASL and AASLD Criteria

  2010influential reference
• Diagnostic efficacy of gadoxetic acid-enhanced MRI in the detection of hepatocellular carcinomas: comparison with gadopentetate dimeglumine.

  2010cited by this paper
• Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

  2010cited by this paper
• Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.

  2010cited by this paper
• The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis

  2010cited by this paper
• Ferucarbotran-Enhanced Magnetic Resonance Imaging Versus Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Preoperative Detection of Hepatocellular Carcinoma: Initial Experience

  2010cited by this paper
• Improved diagnosis of well‐differentiated hepatocellular carcinoma with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid‐enhanced magnetic resonance imaging and Sonazoid contrast‐enhanced ultrasonography

  2010cited by this paper
• Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.

  2010cited by this paper
• Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Differentiating Small Hepatocellular Carcinomas (≤2 cm in Diameter) From Arterial Enhancing Pseudolesions: Special Emphasis on Hepatobiliary Phase Imaging

  2010cited by this paper
• Perfusion magnetic resonance imaging of the liver.

  2010cited by this paper
• Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver

  2010cited by this paper
• Detection of Hepatocellular Carcinoma with PET/CT: A Prospective Comparison of 18F-Fluorocholine and 18F-FDG in Patients with Cirrhosis or Chronic Liver Disease

  2010cited by this paper
• Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging.

  2010cited by this paper
• Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.

  2010cited by this paper
• Multidetector-row computed tomography (MDCT) for the diagnosis of hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological correlation with liver explants

  2010cited by this paper
• Evaluation of hepatocellular carcinoma using contrast-enhanced ultrasonography: correlation with microvessel morphology.

  2010cited by this paper
• Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin.

  2010cited by this paper
• Editorial: The Radiological Diagnosis of Hepatocellular Carcinoma

  2010cited by this paper
• Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate‐ and ferucarbotran‐enhanced magnetic resonance imaging

  2010cited by this paper
• Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.

  2010cited by this paper
• Comparison of gadoxetic acid-enhanced MRI and superparamagnetic iron oxide-enhanced MRI for the detection of hepatocellular carcinoma.

  2010influential reference
• Detection of Small Hepatocellular Carcinoma: Can Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Replace Combining Gadopentetate Dimeglumine-Enhanced and Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging?

  2010cited by this paper
• Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients.

  2009cited by this paper
• Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma

  2009cited by this paper
• Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.

  2009cited by this paper
• Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver.

  2009cited by this paper
• Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound.

  2009cited by this paper
• Small hypervascular hepatocellular carcinomas: value of “washout” on gadolinium-enhanced dynamic MR imaging compared to superparamagnetic iron oxide-enhanced imaging

  2009cited by this paper
• Additional Value of SPIO-Enhanced MR Imaging for the Noninvasive Imaging Diagnosis of Hepatocellular Carcinoma in Cirrhotic Liver

  2009cited by this paper
• Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosis

  2009cited by this paper
• Small (≤3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT

  2009cited by this paper
• Cholangiocarcinoma in cirrhosis: Absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma

  2009cited by this paper
• Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images

  2009influential reference
• Can hepatocellular cancer screening increase the proportion of long-term survivors?

  2009cited by this paper
• Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma.

  2009influential reference
• Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

  2009cited by this paper
• Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation.

  2009cited by this paper
• Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.

  2009cited by this paper
• Added value of breathhold diffusion‐weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast‐enhanced MRI alone using receiver operating characteristic curve analysis

  2009cited by this paper
• Imaging of Proliferation in Hepatocellular Carcinoma with the In Vivo Marker 18F-Fluorothymidine

  2009cited by this paper
• Detection of Hepatocellular Carcinoma: Gadoxetic Acid-Enhanced 3-Dimensional Magnetic Resonance Imaging Versus Multi-Detector Row Computed Tomography

  2009cited by this paper
• Added value of diffusion‐weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas

  2009cited by this paper
• Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.

  2009cited by this paper
• The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis

  2009cited by this paper
• High‐b‐value diffusion‐weighted MR imaging of hepatocellular lesions: Estimation of grade of malignancy of hepatocellular carcinoma

  2009cited by this paper
• Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

  2009cited by this paper
• MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.

  2009cited by this paper
• Diagnostic Performance of Multidetector Row Computed Tomography, Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging, and Dual-Contrast Magnetic Resonance Imaging in Predicting the Appropriateness of a Transplant Recipient Based on Milan Criteria: Correlation With Histopathological Find

  2009cited by this paper
• Detection of small hepatocellular carcinoma: comparison of conventional gadolinium-enhanced MRI with gadolinium-enhanced MRI after the administration of ferucarbotran.

  2009cited by this paper
• Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI.

  2008cited by this paper
• Radiological diagnosis of hepatocellular carcinoma

  2008cited by this paper
• Accuracy of detecting hepatocellular carcinomas before liver transplantation

  2008cited by this paper
• A Prospective Evaluation of 18F-FDG and 11C-Acetate PET/CT for Detection of Primary and Metastatic Hepatocellular Carcinoma

  2008cited by this paper
• Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.

  2008cited by this paper
• Combined SPIO–gadolinium magnetic resonance imaging in cirrhotic patients: negative predictive value and role in screening for hepatocellular carcinoma

  2008cited by this paper
• Detection of Hepatocellular Carcinoma Using 11C-Choline PET: Comparison with 18F-FDG PET

  2008cited by this paper
• Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis

  2008cited by this paper
• Large (>or=2 cm) non-hypervascular nodules depicted on MRI in the cirrhotic liver: fate and implications.

  2008cited by this paper
• Contrast‐enhanced sonography in the diagnosis of small hepatocellular carcinoma ≤2 cm

  2008cited by this paper
• Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma.

  2008cited by this paper
• Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma

  2008cited by this paper
• MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies.

  2008cited by this paper
• Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation.

  2007cited by this paper
• Dual-Tracer PET/CT Imaging in Evaluation of Metastatic Hepatocellular Carcinoma

  2007cited by this paper
• Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma

  2007cited by this paper
• F-Fluorodeoxyglucose Positron Emission Tomography in Detecting Extrahepatic Metastasis in Pretreatment Staging of Hepatocellular Carcinoma

  2007cited by this paper
• Hypervascular hepatocellular carcinoma: Combined dynamic MDCT and SPIO‐enhanced MRI versus combined CTHA and CTAP

  2007influential reference
• PET/CT in patients with hepatocellular carcinoma using [18F]fluorocholine: preliminary comparison with [18F]FDG PET/CT

  2006cited by this paper
• Accuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review

  2006cited by this paper
• Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy

  2006cited by this paper
• Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images

  2005cited by this paper
• LIVER FAILURE AND LIVER DISEASE

  2005cited by this paper
• Management of hepatocellular carcinoma

  2005cited by this paper
• Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially‐enhancing liver mass

  2005cited by this paper
• 18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma

  2004cited by this paper
• Randomized controlled trial of screening for hepatocellular carcinoma

  2004cited by this paper
• Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.

  2003cited by this paper
• Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue.

  2003cited by this paper
• Test Characteristics of -Fetoprotein for Detecting Hepatocellular Carcinoma in Patients with Hepatitis C

  2003cited by this paper
• Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan

  2002cited by this paper
• Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria

  2002influential reference
• Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: A systematic review

  2002cited by this paper
• Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

  2001cited by this paper
• Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

  2001influential reference
• Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis

  2001cited by this paper
• Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis.

  2000cited by this paper
• Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer.

  1999cited by this paper

• Liver diseases: epidemiology, causes, trends and predictions

  2025cites this paper
• Value of enhancing capsule for diagnosing hepatocellular carcinoma on MRI: implications for simplifying LI-RADS

  2025cites this paper
• To Biopsy or Not to Biopsy? Re-examining the Role of Tissue Diagnosis in Hepatocellular Carcinoma.

  2025cites this paper
• Optimizing Hepatocellular Carcinoma Screening: A Comparative Simulated Abbreviated MRI Protocol Study

  2025cites this paper
• Prostate-specific membrane antigen-targeting radiopharmaceuticals: a new frontier in hepatic malignancies

  2025cites this paper
• HCC in the Era of Emerging MASH: The Role of Ultrasound in Surveillance and New Sonographic Features in Diagnosis

  2025influential citation
• Diagnostic and prognostic performances of GALAD score in staging and 1-year mortality of hepatocellular carcinoma: A prospective study

  2024cites this paper
• A high-throughput test enables specific detection of hepatocellular carcinoma

  2023cites this paper
• A Cascaded Approach for ultraly High Performance Lesion Detection and False Positive Removal in Liver CT Scans

  2023cites this paper
• Prognostic factors for outcome of liver transplantion hepatitis C cirrhosis

  2023cites this paper
• Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study

  2023cites this paper
• Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populations

  2023cites this paper
• Accuracy of Non-Contrast MRI for the Detection of Hepatocellular Carcinoma: A systematic review and meta-analysis

  2022cites this paper
• Is Shear Wave Elastography Effective for Characterization of Hepatic Focal Lesions?

  2022cites this paper
• epi Liver a novel tumor specific, high throughput and cost-effective blood test for specific detection of liver cancer (HCC)

  2021cites this paper
• epiLiver a novel tumor specific, high throughput and cost-effective blood test for specific detection of liver cancer (HCC)

  2021cites this paper
• Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis

  2021cites this paper
• Is Glypican-3 useful Diagnostic Marker that Distinguishes Hepatocellular Carcinoma from Liver Cirrhosis?

  2020cites this paper
• Cone-Beam Computed Tomography-Hepatic Arteriography as a Diagnostic Tool for Small Hypervascular Hepatocellular Carcinomas: Method and Clinical Implications

  2020cites this paper
• A review of conventional and newer generation microwave ablation systems for hepatocellular carcinoma

  2020cites this paper
• [68 Ga]Ga-Prostate-Specific Membrane Antigen PET/CT: a novel method for imaging patients with hepatocellular carcinoma

  2020influential citation
• Improving B-mode ultrasound diagnostic performance for focal liver lesions using deep learning: A multicentre study

  2020cites this paper
• Cancer Prevention in Low-Resource Countries: An Overview of the Opportunity.

  2020cites this paper
• Nanomedicinal delivery systems for intelligent treatment of hepatocellular carcinoma

  2019cites this paper
• Nomograms in Hepatectomy Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma

  2019cites this paper
• MODERN THERAPEUTIC STRATEGIES FOR CLEVER TARGETING AND TREATMENT OF HEPATOCELLULAR CARCINOMA

  2019cites this paper
• A global view of hepatocellular carcinoma: trends, risk, prevention and management

  2019cites this paper
• The Diagnostic Performance of Liver MRI without Intravenous Contrast for Detecting Hepatocellular Carcinoma: A Case-Controlled Feasibility Study

  2018influential citation
• GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score

  2018cites this paper
• ALBI SCORE AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH COMPENSATED CIRRHOSIS RESECTED FOR HEPATOCELLULAR CARCINOMA: EXPLORATORY EVALUATION IN RELATIONSHIP TO PALBI AND MELD LIVER FUNCTION SCORES

  2018cites this paper
• Clinical characteristics and outcomes of hepatocellular carcinoma: results from prospective study, from a tertiary referral center in 
Sri Lanka

  2018cites this paper
• Diagnostic précoce des carcinomes hépatocellulaires

  2018cites this paper
• Diagnostic utility of CD10 immunohistochemical staining on cellblock in differentiating hepatocellular carcinoma from secondary malignancies of liver

  2018cites this paper
• Diagnosis and Staging of Cholangiocarcinoma

  2018cites this paper
• Pathological variants of hepatocellular carcinoma on MRI: emphasis on histopathologic correlation

  2018cites this paper
• Factors predicting outcomes of microwave ablation of small hepatocellular carcinoma

  2017cites this paper
• Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging

  2017cites this paper
• Increased interreader agreement in diagnosis of hepatocellular carcinoma using an adapted LI-RADS algorithm.

  2017cites this paper
• Three-dimensional Image Fusion Guidance for Transjugular Intrahepatic Portosystemic Shunt Placement

  2017cites this paper
• Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma

  2017cites this paper
• Biases in the reporting of hepatocellular carcinoma tumor sizes on the liver transplant waiting list

  2017cites this paper
• Validierung relevanter Prognosefaktoren des Leberzellkarzinoms in Bezug auf Therapiestrategie und Outcome

  2017cites this paper
• Biomarker development for hepatocellular carcinoma early detection: current and future perspectives.

  2017cites this paper
• Radiofrequency Ablation Combined With Percutaneous Ethanol Injection in Treatment of Medium Sized Lesions 3-5 cm Hepatocellular Carcinoma

  2017cites this paper
• Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase

  2017cites this paper
• Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening.

  2017cites this paper
• Reliability, Validity, and Reader Acceptance of LI-RADS-An In-depth Analysis.

  2016cites this paper
• Imaging Outcomes of Liver Imaging Reporting and Data System Version 2014 Category 2, 3, and 4 Observations Detected at CT and MR Imaging.

  2016cites this paper
• Focal liver lesions found incidentally.

  2016cites this paper
• imaging Outcomes of liver imaging reporting and Data system Version 2014 category 2, 3, and 4 Observations Detected at cT and Mr imaging 1

  2016cites this paper
• Title Imaging Outcomes of Liver Imaging Reporting and Data System Version 2014 Category 2 , 3 , and 4 Observations Detected at CT and MR Imaging Permalink

  2016cites this paper
• Current role of microwave ablation in the treatment of small hepatocellular carcinomas

  2016cites this paper
• GASTROINTESTINAL IMAGING : Imaging Outcomes of Liver Imaging Reporting and Data System Observations

  2016cites this paper
• Current Guidelines for the Diagnosis and Management of Hepatocellular Carcinoma: A Comparative Review.

  2016cites this paper
• Suppression of Hepatocellular Carcinoma by Inhibition of Overexpressed Ornithine Aminotransferase.

  2015cites this paper
• Concurrent hepatic hemangioma and solitary fibrous tumor: diagnosis and management

  2015cites this paper
• Recent advances in the imaging of hepatocellular carcinoma

  2015cites this paper
• Diagnostic per-patient accuracy of an abbreviated hepatobiliary phase gadoxetic acid-enhanced MRI for hepatocellular carcinoma surveillance.

  2015cites this paper
• Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment.

  2015cites this paper
• Consensus on Hepatobiliary Imaging Practice Guidelines

  2015cites this paper
• Hepatocellular carcinoma: Advances in diagnostic imaging.

  2015cites this paper
• Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid).

  2015cites this paper
• Review of Commonly Used Serum Tumor Markers and Their Relevance for Image Interpretation

  2015cites this paper
• Intravenous contrast media optimization at computed tomography

  2015cites this paper
• Abdomen: Solid Organs

  2015cites this paper
• points about OCI, screening of OCI should be taken into account, particularly in special groups like baby boomers.

  2015cites this paper
• Ethics and informed consent in patients with hepatocellular carcinoma: Changing roles for hepatologist and radiologist

  2015cites this paper
• Assessing a microrNA panel in diagnosing early cholangiocarcinoma

  2015cites this paper
• Screening for occult hepatitis C virus infection: Does it need special attention?

  2015cites this paper
• Feasibility of blood oxygenation level-dependent MRI at 3T in the characterization of hepatic tumors

  2014cites this paper
• Nodule in Liver: Investigations, Differential Diagnosis and Follow-up.

  2014cites this paper
• Clinical Implications of Liver Malignancies

  2014cites this paper
• The biological and clinical challenge of liver cancer heterogeneity.

  2014cites this paper
• Causes and Stages of Hepatocellular Carcinoma at Patient Presentation at a Tertiary Medical Center in Western Saudi Arabia

  2014cites this paper
• LIVER MRI IN ONCOLOGICAL PATIENTS: WHAT BENEFITS CAN WE GET? A PRACTICAL MINIREVIEW

  2014cites this paper
• Noncontrast MRI with diffusion-weighted imaging as the sole imaging modality for detecting liver malignancy in patients with high risk for hepatocellular carcinoma.

  2014cites this paper
• Radiological features of hepatocellular carcinoma.

  2014cites this paper
• Results of salvage liver transplantation

  2014cites this paper
• Impact of Viral Hepatitis on Outcomes after Liver Resection for Hepatocellular Carcinoma: Results from a North American Center

  2014cites this paper
• Impact of Viral Hepatitis on Outcomes after Liver Resection for Hepatocellular Carcinoma: Results from a North American Center

  2014cites this paper
• Role of local ablative therapy for hepatocellular carcinoma.

  2014cites this paper
• Imaging pitfalls in MDCT of hepatocellular carcinoma: an imaging collection of lessons learned

  2013cites this paper
• Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma – feasibility and clinical response

  2013cites this paper
• Early hepatocellular carcinoma - is there such a thing as too early?

  2013cites this paper
• Consensus report of the Fifth International Forum for Liver MRI.

  2013cites this paper
• 258 HYPOFRACTIONATED CARBON ION THERAPY DELIVERED WITH SCANNED ION BEAMS FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA – FEASIBILITY AND CLINICAL RESPONSE

  2013cites this paper
• Non-invasive diagnosis of small nodules in cirrhosis.

  2013cites this paper
• The Royal Australian and New Zealand College of Radiologists 64th Annual Scientific Meeting

  2013cites this paper
• Diagnostic value of glypican-3 in alpha fetoprotein negative hepatocellular carcinoma patients.

  2013cites this paper
• Plasma Osteopontin Level as a Diagnostic Marker of Hepatocellular Carcinoma in Patients with Radiological Evidence of Focal Hepatic Lesions

  2013cites this paper
• Focal lesions in the cirrhotic liver

  2013cites this paper
• Detecting hepatocellular carcinoma in gadoxetic-acid-enhanced hepatobiliary-phase MR imaging at 3T: comparing high and low flip angle

  2013cites this paper
• Contrast ultrasound in hepatocellular carcinoma at a tertiary liver center: First Indian experience.

  2013cites this paper
• Evaluation of Liver Tumors Using Acoustic Radiation Force Impulse Elastography and Correlation With Histologic Data

  2013cites this paper
• Optimization of intravenous contrast media at computed tomography

  2012cites this paper
• INTRAVENOUS CONTRAST MEDIA AT COMPUTED TOMOGRAPHY

  2012cites this paper
• New Paradigm for Management of Hepatocellular Carcinoma by Imaging

  2012cites this paper
• Hepatocellular carcinoma: natural history, current management, and emerging tools

  2012cites this paper
• New Imaging Techniques for 90 Y Microsphere Radioembolization

  2011cites this paper
• Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin.

  2010cites this paper